CompletedInterventionalPhase 4Last updated Jul 20, 2020

Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting

Effects of Ondansetron Dose and Timing on Rates of Post-operative Nausea and Vomiting

Overview

ClinicalTrials.gov ID: NCT03297021
Lead Sponsor: Icahn School of Medicine at Mount SinaiOTHER
Brief Summary: The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.
Study Type: Interventional

Status

Study Record Dates

NCT04719741Unknown status

Drug and Dose Adjustment in Preventing Postoperative Nausea and Vomiting

NCT02143531Completed

Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting

NCT06886230Completed

Ondansetron vs. Dexamethasone for Postoperative Nausea

NCT01474915Completed

Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

NCT02966041Completed

Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting

NCT06254131Completed

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section